Loading
Total declarations
Company
▲ Purchases (16 ops.)
▼ Sales (0 ops.)
Latest filing published 10 Dec 2025 for M&G plc, €316.
Filing timeline
BuySaleBenoît Macé
Insider track record
Disclosed buys
16
Disclosed sells
0
Signal history
Closed purchases
Market purchases
16
Positive at T+90
63%
Median T+90
+3.7%
Based on 16 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- +35.0%Entry £1.99 · Close at T+365 £2.68
- +34.8%Entry £1.95 · Close at T+365 £2.63
- +24.5%Entry £2.05 · Close at T+365 £2.55
- +22.7%Entry £2.07 · Close at T+365 £2.54
- +26.5%Entry £2.10 · Close at T+365 £2.66
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Benoît Macé: trading record in brief
At M&G plc, Benoît Macé, Chief Strategy & Transformation Officer, has a record made mostly of purchases: 16 open-market buys, all with an amount, for EUR 420,934 in total and a median of EUR 23,615. No sale is recorded; the 47 filings published from December 12, 2022 to December 10, 2025 also hold 31 grants.
The three largest purchases date from November 27, 2023 (EUR 46,822), October 3, 2023 (EUR 45,113) and June 20, 2023 (EUR 40,258), all in 2023. By calendar, 2 filings in 2022, 7 in 2023, 21 in 2024 and 17 in 2025; the last twelve months hold 3, with no purchase.
For the 16 purchases with a 90-day result, the stored median is 3.7%, with 63% positive; past results as recorded, not a forecast. Macé has 4, 4 and 4 own market trades within 30 days of colleagues at M&G plc, in that order. In the same direction: 4, 0 and 0. Names in order: Edward Braham, Clive Bolton and Joseph Pinto. The median publication delay is 2 days.
Companies and markets linked to Benoît Macé
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations47 total
81 shares@ £3.40740.1% of flowXLONISIN GB00BKFB1C65RNS:00e947ac-b773-4073-9a3f-93e331f3d598-2
82 shares@ £3.30490.1% of flowXLONISIN GB00BKFB1C65RNS:1eeaf017-8062-434a-9f60-56af0bba7286-3
3,424 shares@ £2.5592.2% of flowISIN GB00BKFB1C65RNS:5871429
49 shares@ £2.53160.1% of flowXLONISIN GB00BKFB1C65RNS:5870105-5
88 shares@ £2.89770.1% of flowXLONISIN GB00BKFB1C65RNS:5858455-2
87 shares@ £2.96550.1% of flowXLONISIN GB00BKFB1C65RNS:5815816-2
87 shares@ £3.000.1% of flowXLONISIN GB00BKFB1C65RNS:5777815-2
87 shares@ £2.9540.1% of flowXLONISIN GB00BKFB1C65RNS:5734967-2
90 shares@ £2.74440.1% of flowXLONISIN GB00BKFB1C65RNS:5690075-2
7,609 shares@ £2.1864.4% of flowISIN GB00BKFB1C65RNS:5656104-3
179 shares@ £1.21230.1% of flowXLONISIN GB00BKFB1C65RNS:5652604-3
00.0% of flowOutside a trading venueISIN GB00BKFB1C65RNS:5651899-5
129 shares@ £1.37210.0% of flowXLONISIN GB00BKFB1C65RNS:5614492-2
00.0% of flowOutside a trading venueISIN GB00BKFB1C65RNS:5599436-4
105 shares@ £2.03810.1% of flowXLONISIN GB00BKFB1C65RNS:5571682-2
105 shares@ £2.02860.1% of flowXLONISIN GB00BKFB1C65RNS:5534659-2
117 shares@ £1.66670.1% of flowXLONISIN GB00BKFB1C65RNS:5498420-2
112 shares@ £1.80360.1% of flowXLONISIN GB00BKFB1C65RNS:5462996-2
112 shares@ £1.75890.1% of flowXLONISIN GB00BKFB1C65RNS:5426915-2
10,017 shares@ £1.98655.3% of flowISIN GB00BKFB1C65RNS:5422668
Canonical exit: 6 Feb 2025 (T+90)
3,229 shares@ £2.0671.8% of flowISIN GB00BKFB1C65RNS:5400456-3
Canonical exit: 21 Jan 2025 (T+90)
00.0% of flowOutside a trading venueISIN GB00BKFB1C65RNS:5397063-5
111 shares@ £1.84680.1% of flowXLONISIN GB00BKFB1C65RNS:5386287-2
9,510 shares@ £2.09245.2% of flowISIN GB00BKFB1C65RNS:5377462
Canonical exit: 2 Jan 2025 (T+90)
108 shares@ £1.92590.1% of flowXLONISIN GB00BKFB1C65RNS:5343517-2
25 of 47 declarations
